Liver cirrhosis and hepatocellular carcinoma in Mexico:

impact of chronic infection by hepatitis viruses B and C 

Autores: Torres Poveda Kirvis Janneth, Burguete García Ana I., Madrid Marina Vicente

Fragmento

Data on the prevalence of chronic liver disease (CLD) in Mexico, derived from selected series of hospitalized patients or fron mortality registers, underestimate the prevalence of CLD. The etiology of liver disease is unknown in approximately 10% of patients with abnormal results on liver function tests. Cirrhosis is considered to be the most important risk factor for hepatocellular carcinoma (HCC). Several studies have indicated that 1-4% of all cirrhotic patients per year will develop HCC, according to the leading cause of the cirrhosis as reported by Méndez-Sánchez, et al. During 2006 the Ministry of Health in Mexico reported 122,170 (87.3%) avoidable deaths fron liver cirrhosis between 2000 and 2004. Liver cirrhosis is the second cause of death in the 15- to 64-year-old age group; being three times higher in men than in women. The liver cirrhosis mortality in Mexico is substantially higher than in high-income countries.

Palabras clave:

2011-09-14   |   764 visitas   |   Evalua este artículo 0 valoraciones

Vol. 10 Núm.4. Octubre-Diciembre 2011 Pags. 556-558 Ann Hepatol 2011; 10(4)